Related Experiment Video

Updated: Aug 16, 2026

Three-Dimensional (3D) Tumor Spheroid Invasion Assay
12:19

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Published on: May 1, 2015

The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective

Thomas R Geiger1, Daniel S Peeper

  • 1Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Cancer Research
|August 17, 2005
PubMed

Insights

Cancer cells resisting anoikis (detachment-induced apoptosis) can metastasize. We found the neurotrophic receptor TrkB promotes anoikis suppression, leading to highly invasive and metastatic tumors in mice, suggesting TrkB as a potential cancer therapy target.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Metastasis Research

Background:

  • Anoikis, or detachment-induced apoptosis, is a crucial barrier preventing cancer cell survival and metastasis.
  • Understanding mechanisms that suppress anoikis is vital for deciphering cancer cell dissemination.

Purpose of the Study:

  • To identify novel suppressors of anoikis through a functional genetic screen.
  • To investigate the role of the neurotrophic receptor TrkB in anoikis resistance and cancer metastasis.
  • To evaluate TrkB as a potential therapeutic target for human malignancies.

Main Methods:

  • Conducted a functional screen to identify genes that suppress anoikis.
  • Utilized in vivo models (subcutaneous inoculation in mice) to assess tumor invasion and metastasis.
  • Analyzed the expression and function of the neurotrophic receptor TrkB in cancer cells.

Main Results:

  • Identified the neurotrophic receptor TrkB as a suppressor of anoikis.
  • TrkB-expressing cancer cells formed highly invasive and metastatic tumors when inoculated in mice.
  • These findings highlight TrkB's pro-metastatic role.

Conclusions:

  • TrkB-mediated suppression of anoikis is a critical step in cancer cell metastasis.
  • TrkB's role in promoting invasion and metastasis suggests its potential as a therapeutic target in human cancers.
  • Further investigation into TrkB's feasibility as a cancer therapy target is warranted.

More Related Videos

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...